M&A for the foreseeable future falls in three segments: 1) thriving companies – e.g. direct to consumer brands, healthcare, technology, and essential services; 2) strong companies who have enough cash to weather the storm; and 3) companies that will become distressed target.
In this webinar, we’ll cover:
-Current state of M&A Activity
-Bridging valuation and financing gaps
-Current deal structures
-Overview of the distressed deals and troubled transactions
-Current legal issues, including material adverse condition, post-closing covenants, PPP loan compliance, and use of rep & warranty insurance.
The webinar will feature these exciting experts:
David Kupetz, Partner of Sulmeyer Kupetz, an attorney who specializes in troubled transactions, crisis avoidance consultation, workouts, restructurings, reorganizations, bankruptcies, receiverships, and assignments for the benefits of creditors.
Channing Hamlet, Managing Director with Objective Capital Partners. He serves as an execution leader for the firm’s M&A and Valuation Practice and leads the firm’s Business Services Practice. He brings more than 25 years’ experience with investment banking and business valuation to his clients.
Constantine Potamianos, M&A Partner with Fogel & Potamianos LLP, whose experience includes buy and sell side mergers and acquisitions, including reverse mergers, domestic and foreign stock acquisitions, and domestic and foreign asset acquisitions.
The panel will be moderated by Jerome Fogel, Corporate and M&A partner with Fogel & Potamianos LLP.